Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This was a single centre, single-blind, randomized, balanced, combined single dose study
under fasting condition and multiple doses study under fed condition with normal
diabetic-meal, two-period, two-sequence cross-over study to to compare the bioavailability of
metformin hydrochloride 500 mg extended release caplet (test drug) and metformin
hydrochloride 500 mg prolonged release tablet (reference formulation).